Pharmaceutical companies are careful to introduce ‘Viagra for women’ in the domestic market
When it comes to introduction of ‘Addvi(flibanserine)’, a FDA-approved female hyposexuality treatment, domestic pharmaceutical companies have been careful, meaning that more verification in its effectiveness and marketability is needed.
Having the FDA approval as a chance, however, the product h...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
